Literature DB >> 22124040

FGF1 containing biodegradable device with peripheral nerve grafts induces corticospinal tract regeneration and motor evoked potentials after spinal cord resection.

Jonathan Nordblom1, Jonas K E Persson, Jonas Aberg, Hans Blom, Håkan Engqvist, Hjalmar Brismar, Johan Sjödahl, Anna Josephson, Arvid Frostell, Sebastian Thams, Lou Brundin, Mikael Svensson, Per Mattsson.   

Abstract

PURPOSE: Repairing the spinal cord with peripheral nerve grafts (PNG) and adjuvant acidic fibroblast growth factor (FGF1) has previously resulted in partial functional recovery. To aid microsurgical placement of PNGs, a graft holder device was previously developed by our group. In hope for a translational development we now investigate a new biodegradable graft holder device containing PNGs with or without FGF1.
METHODS: Rats were subjected to a T11 spinal cord resection with subsequent repair using twelve white-to-grey matter oriented PNGs prepositioned in a biodegradable device with or without slow release of FGF1. Animals were evaluated with BBB-score, electrophysiology and immunohistochemistry including anterograde BDA tracing.
RESULTS: Motor evoked potentials (MEP) in the lower limb reappeared at 20 weeks after grafting. MEP responses were further improved in the group treated with adjuvant FGF1. Reappearance of MEPs was paralleled by NF-positive fibers and anterogradely traced corticospinal fibers distal to the injury. BBB-scores improved in repaired animals.
CONCLUSIONS: The results continue to support that the combination of PNGs and FGF1 may be a regeneration strategy to reinnervate the caudal spinal cord. The new device induced robust MEPs augmented by FGF1, and may be considered for translational research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22124040     DOI: 10.3233/RNN-2011-0623

Source DB:  PubMed          Journal:  Restor Neurol Neurosci        ISSN: 0922-6028            Impact factor:   2.406


  5 in total

1.  Advancing Peripheral Nerve Graft Transplantation for Incomplete Spinal Cord Injury Repair.

Authors:  Jacob Kjell; Mikael Svensson
Journal:  Front Cell Neurosci       Date:  2022-04-28       Impact factor: 6.147

Review 2.  Spinal cord injury pharmacotherapy: Current research & development and competitive commercial landscape as of 2015.

Authors:  Jason R Guercio; Jason E Kralic; Eric J Marrotte; Michael L James
Journal:  J Spinal Cord Med       Date:  2018-02-27       Impact factor: 1.985

Review 3.  Corticospinal reorganization after spinal cord injury.

Authors:  Martin Oudega; Monica A Perez
Journal:  J Physiol       Date:  2012-05-14       Impact factor: 5.182

4.  Neurological function following intra-neural injection of fluorescent neuronal tracers in rats.

Authors:  Wen Hu; Dan Liu; Yanping Zhang; Zhongyi Shen; Tianwen Gu; Xiaosong Gu; Jianhui Gu
Journal:  Neural Regen Res       Date:  2013-05-15       Impact factor: 5.135

5.  Guiding Device for Precision Grafting of Peripheral Nerves in Complete Thoracic Spinal Cord Injury: Design and Sizing for Clinical Trial.

Authors:  Arvid Frostell; Per Mattsson; Mikael Svensson
Journal:  Front Neurol       Date:  2018-05-22       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.